At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
New hearing aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Hearing Aid Benefit
In Brief
A clinical study evaluating New hearing aid for Hearing Loss, Sensorineural. Completed, enrolled 15 participants across 1 site.
Detailed Summary
The present study will investigate the benefit of hearing aids for speech intelligibility (in both quiet and noisy environments) compared to the unaided condition. Participants will include adults with moderate to moderately severe hearing impairment. The participants will complete laboratory-based speech intelligibility assessments with binaural hearing aids and without hearing aids.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss, Sensorineural
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJan 2022
First PostedJan 2022
Primary CompletionMar 2022
TodayJul 2026
First PostedJan 20, 2022
Enrollment StartJan 18, 2022
Primary CompletionMar 4, 2022
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 4.5 years ago
Interventions
New hearing aiddevice
Participants will complete testing while using a novel hearing aid which has been fit to compensate for their hearing loss.